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Beside the wel l -known cardiac side-effects, Fenoterol has a s igni-
ficant in f luence on the glucose metabol ism, as shown by U N B E H A U N
(3) and CONRADT (1 ) . By the concentration of 2.3-DPG the glucose
metabolism also has an inf luence on the P™ of the maternal haemo-
glob in and thus on the Op-saturat ion of tne maternal blood. On the
other hand, M E I E R et a l . (2) showed that after a therapy of Feno-
terol given int ravenously for at least 1 week, a shif t of the C^-
disso ciation curve to the r ight can be noticed.
Hence it was to scrutinize by in vitro tests, whether there was a
direct in f luence of Fenoterol on the erythrocytes, respectively on
the P™ of maternal haemoglobin. For that purpose, blood was incu-
bated at. a temperature of 37° C with the hundredfold substance con-
centration of Fenoterol, that is wi th 50 Mg/100 m l , for a time up
to 28 hours. To the incubat ion sediment 150 mg% glucose and 0,2 ml
of an Ampic i l l in -Refobac in-so lu t ion were added, the analysis was
done by photometric means wi th the Erythrox-system. The 2.3-DPG-
concentration was defined encymatically. There are no differences
between the erythrocytes incubated w i th , respectively without Feno-
terol. The osc i l la t ion of the Prg-rates reflects osci l la tory pheno-
mena inside the metabolism of the erythrocytes. The alterion of the
osc i l l a t i on frequency takes 8 hours. The 2.3-DPG-levels oscil late
in the same way as the PgQ-rates. The same characteristics - depen-
dent on time - of the P™ and the 2.3-DPG-levels were shown by
2-day-old erythrocytes as we l l as 20-day-old erythrocytes which
were incubated with and without Fenoterol. Consequently, Fenoterol
has no inf luence on the osci l lat ion parameter of the red blood cell.
From the characteristics of the erythrocytes incubated wi th Feno-
terol it might be concluded that the ß-receptors on the erythrocyte
membrane are not either existent or avai lable .
The in v ivo studies were conducted on 10 patients in the last
trimenon. We took venous blood from the patients before b e g i n n i n g
the therapy as well as 3, 6 and 24 hours afterwards. From the
washed erythrocyte suspension the ha l f sa tura t ion pressure was
measured by the Erythrox-system. From a further share of this blood
the 2.3-DPG-content and acid-base-status was defined. We found in
a l l patients a tending decrease of P5Q wi th a maximum at 6 hours
after therapy was started. As a matter of fact, the basic values of
the PSQ were reached again after 24 hours. The 2.3-DPG-concentraticn
of the erythrocytes showed identical alterations. The lowest concen-
tration was measured also 6 hours after the begin of the therapy,
whi l s t 24 hours after the begin of the therapy the 2.3-DPG-concen-
tration in the red blood cell corresponded with the one before the
begin of the therapy. The P02-value of the blood testings show an
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exactly contrary characteristic of the tested parameter. Already
3 hours after the begin of the therapy the ?Q^ i n the maternal ve-
nous blood is raised and then decreases aqain wi th in 24 hours while
us ing Fenoterol. According to the decrease of the P™ we f ind a
raised (^-content of the maternal haemoglobin.
Hence, among other reasons, the decrease of the 2.3-DPG-concentra-
tion is regarded as causative for the alteration of the PJ-Q in the
maternal blood. The shif t to the left of the Op-dissociat ion curve
leads to a reduced Oxygen-consumption of the maternal blood by the
fetus. Thus , wi th a s imul taneously exist ing insuf f ic iency of the
placenta an r isk for the fetus dur ing the early stage of tocolysis
has to be discussed. In an extensive research the exact biochemical
mechanism of this alteration w i l l be verif ied in vivo on a larger
number of patients.
B I B L I O G R A P H Y
1. CONRADT, A . , C .M. SCHLOTTER, V. U N B E H A U N :
L ipo lys i s , Ketonaemia, Estrogen- and Gestagen Concentra-
tions d u r i n g Short Time In fus ion Therapy with Beta-
mimet ics .
In: H. Weidinger ( E d ) , Labour Inh ib i t ion Betamimetic Drugs
in Obstetrics, G. Fischer, Stuttgart, New York (1977)
103 - 110
2. M E I E R , U. , F. WOLFF, H.-J. KLINGSPOHR:
Der E i n f l u ß von Fenoterol (Partusisten ) auf die Sauer-
stoff b indungskurven von schwangeren Frauen.
Z. Geburtsh. u. Perinat. 182 (1978) 288 - 293
3. U N B E H A U N , V . , A. CONRADT, C .M. SCHLOTTER:
Untersuchungen über das Verhalten von Parametern des
Kohlenhydrat- und Fettstoffwechsels sowie von humanem
plazentaren Lactogen ( H P L ) und Serum-Kal ium während oraler
Langzeitmedikation von Th 1165 a.
In: H. Jung , F.K. Klöck ( E d . ) : Th 1165 a (Partusisten) bei
der Behand lung in der Gebur tshi l fe und Perinatologie,
G. Thieme, Stuttgart (1975) 1 9 1 - 1 9 5
